Contents
- 1 Akums Drugs and Pharmaceuticals IPO Details
- 2 Akums Drugs and Pharmaceuticals IPO Date
- 3 Lot Size
- 4 Promoter Holding
- 5 Akums Drugs and Pharmaceuticals IPO GMP (Grey Market Premium)
- 6 Akums Drugs and Pharmaceuticals IPO Subscription Status
- 7 Akums Drugs and Pharmaceuticals IPO Allotment Status
- 8 Know About Company
- 9 Akums Drugs and Pharmaceuticals Limited Financial Information
- 10 KIP of Akums Drugs and Pharmaceuticals Limited
- 11 Akums Drugs and Pharmaceuticals Limited IPO Valuation – FY2024
- 12 Peer Group
- 13 Akums Drugs and Pharmaceuticals Limited IPO Registrar
- 14 Akums Drugs and Pharmaceuticals Limited IPO Lead Manager
- 15 Akums Drugs and Pharmaceuticals Limited Contact
- 16 Akums Drugs and Pharmaceuticals Limited IPO Application Form PDF
- 17 FAQs – Akums Drugs and Pharmaceuticals Limited IPO
Akums Drugs and Pharmaceuticals IPO: Akums Drugs and Pharmaceuticals Limited is raising money by selling shares to the public. They plan to collect Rs 1,856.74 crores through this process. Out of this, Rs 680 crore will come from selling 1 crore new shares, and Rs 113.05 crore from selling 1.73 crore existing shares(OFS).
Akums Drugs and Pharmaceuticals IPO is open for subscription on July 30, 2024, and closes on August 1, 2024. The allotment for the IPO is expected on August 2, 2024. Akums Drugs and Pharmaceuticals Mainboard IPO will be listed on BSE NSE with a listing date fixed as August 6, 2024.
Source- Akums Drugs and Pharmaceuticals IPO RHP
Akums Drugs and Pharmaceuticals IPO Details
| Open Date | July 30, 2024 |
| Close Date | August 1, 2024 |
| IPO Size | A total of Rs ₹1,856.74 crores and 2.73 crore shares |
| Fresh Issue | 2.73 Crore Equity Shares |
| Face Value | ₹10 per share |
| IPO Price Band | ₹646 to ₹679 per share |
| IPO Listing on | NSE BSE |
| Lot Size | 22 Shares |
| OFS | Rs 113.05 crore from selling 1.73 crore existing shares. |
| Share Offered to Retail | 10% |
| Share Offered to QIB | 75% |
| Share Offered to HNI | 15% |
| Employee Discount | Rs 64 per share |
Akums Drugs and Pharmaceuticals IPO Date
- IPO Open Date: July 30, 2024
- IPO Close Date: August 1, 2024
- Allotment: August 2, 2024
- Refunds: August 5, 2024
- Shares Credit to Demat: August 5, 2024
- Listing Date: August 6, 2024
Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 22 | ₹14,938 |
| Retail (Max) | 13 | 286 | ₹194,194 |
| S-HNI (Min) | 14 | 308 | ₹209,132 |
| S-HNI (Max) | 66 | 1,452 | ₹985,908 |
| B-HNI (Min) | 67 | 1,474 | ₹1,000,846 |
Promoter Holding
The company’s promoters include Sanjeev Jain, Sandeep Jain, and Akums Master Trust, holding 84.94% of the shares before the issue.
Akums Drugs and Pharmaceuticals IPO GMP (Grey Market Premium)
If you want to knowAkums Drugs and Pharmaceuticals IPO GMP (Grey Market Premium) then please visit our IPO GMP section and get daily updates on grey market premium. We update here all IPOs GMP.
Akums Drugs and Pharmaceuticals IPO Subscription Status
Akums Drugs and Pharmaceuticals IPO subscription starts on July 30, 2024, To get live IPO subscription status data go to our IPO Subscription section and see any ongoing IPO Subscription Status.
Akums Drugs and Pharmaceuticals IPO Allotment Status
To check the Akums Drugs and Pharmaceuticals IPO allotment status go to the IPO registrar website ”Link Intime India Private Limited ” or go to IPO Allotment>>.
You can find here any IPO allotment status. Following some stapes.
- Go to the Link given above.
- Select the IPO Name
- Enter your PAN/ DP ID/ Application No
- Submit details and get the allotment status.
Know About Company
Akums Drugs and Pharmaceuticals Limited
Company Overview:
Founded in 2004, Akums Drugs and Pharmaceuticals Limited operates as a leading pharmaceutical Contract Development and Manufacturing Organization (CDMO), catering to a diverse clientele across India and globally.
Core Services:
- Product Development and Manufacturing: Provides comprehensive services spanning from initial formulation development to large-scale manufacturing.
- Regulatory Compliance: Specializes in preparing and submitting regulatory dossiers for both Indian and international markets, ensuring adherence to stringent regulatory standards.
- Research and Development (R&D): Engages in continuous R&D efforts to innovate and improve pharmaceutical formulations and processes.
- Product Portfolio: Offers a wide array of pharmaceutical products, including tablets, capsules, liquid medicines, injectables, topical preparations, and specialized formulations like gummy bears.
Market Presence:
- Clientele: Manufactures formulations for 26 of India’s top 30 pharmaceutical companies by revenue, highlighting its strong market presence and trusted capabilities.
- Manufacturing Capabilities: Operates 10 state-of-the-art manufacturing facilities with a collective annual production capacity exceeding 49.21 billion units as of September 2023.
Expansion Plans:
- Future Growth: Plans to augment production capabilities with the addition of two new manufacturing units by FY 2025, aiming to meet increasing demand and expand service offerings.
- Quality Standards: Recognized for high-quality manufacturing practices, with several facilities accredited by global regulatory bodies such as EU-GMP, WHO-GMP, and US NSF.
Corporate Vision:
Akums Drugs and Pharmaceuticals Limited is committed to advancing healthcare through innovation, quality, and excellence in pharmaceutical manufacturing and development.
References:
- Official Website: Akums Drugs and Pharmaceuticals Limited
Company’s Clients
Akums Drugs and Pharmaceuticals Limited Financial Information
The financial performance table for Akums Drugs and Pharmaceuticals Limited for the financial years ending March 31, 2024, 2023, and 2022:
| Particulars | 31-Mar-2024 (₹ Crore) | 31-Mar-2023 (₹ Crore) | 31-Mar-2022 (₹ Crore) |
|---|---|---|---|
| Assets | 3,516.37 | 3,266.53 | 3,069.05 |
| Revenue | 4,212.21 | 3,700.93 | 3,694.52 |
| Profit After Tax (PAT) | 0.79 | 97.82 | -250.87 |
| Net Worth | 709.50 | 717.19 | 621.98 |
| Total Borrowing | 491.56 | 536.97 | 357.95 |
These figures are presented in crore (₹ Crore), reflecting Akums Drugs and Pharmaceuticals Limited’s financial performance over the specified periods.
KIP of Akums Drugs and Pharmaceuticals Limited
The financial performance table for the specified financial KPIs of the company for the years ending March 31, 2024, 2023, and 2022, converted into crore (₹ in crore):
| Financial KPIs | 31 March 2024 (₹ Crore) | 31 March 2023 (₹ Crore) |
|---|---|---|
| Revenue from operations | 417.82 | 365.48 |
| EBITDA | 15.70 | 38.41 |
| EBITDA margin | 3.73% | 10.38% |
| EBIT | 3.14 | 27.12 |
| EBIT margin | 0.74% | 7.33% |
| Profit for the year | 0.79 | 97.82 |
| Profit after tax margin | 0.02% | 2.64% |
| Fixed asset turnover ratio | 3.30 | 3.41 |
| Debt-equity ratio | 0.69 | 0.75 |
| Return on equity | 0.11% | 13.52% |
| Return on capital employed | 3.37% | 24.60% |
Akums Drugs and Pharmaceuticals Limited IPO Valuation – FY2024
Certainly! Here’s the table with the financial metrics for the company:
| Financial Metric | Value |
|---|---|
| Earnings Per Share (EPS) | ₹-0.28 per Equity Share |
| Price/Earnings (P/E) Ratio | N/A |
| Return on Net Worth (RoNW) | -0.57% |
| Net Asset Value (NAV) | ₹49.59 per Equity Share |
Peer Group
- Divi’s Laboratories
- Suven Pharma
- Gland Pharma
- Torrent Pharma
- Alkem Laboratories
- Eris Lifesciences
- JB Chemicals
- Mankind Pharma
- Innova Captab
Akums Drugs and Pharmaceuticals Limited IPO Registrar
Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg
Vikhroli (West)
Mumbai 400 083
Maharashtra, India
Tel: +91 810 811 4949
E-mail: akumsdrugs.ipo@linkintime.co.in
Website: www.linkintime.co.in
Akums Drugs and Pharmaceuticals Limited IPO Lead Manager
- ICICI Securities Limited
- Axis Bank Limited
- Citigroup Global Markets India Private Limited
- Ambit Private Limited
Akums Drugs and Pharmaceuticals Limited Contact
Akums Drugs and Pharmaceuticals Limited
304, Mohan Place,
LSC Saraswati Vihar,
Delhi – 110 034
Phone: +91 11 6904 1000
Email: cs@akums.net
Website: http://www.akums.in/
Akums Drugs and Pharmaceuticals Limited IPO Application Form PDF
To download the Akums Drugs and Pharmaceuticals Limited IPO application form Check out the Application Form Download ASBA IPO Forms PDF.
FAQs – Akums Drugs and Pharmaceuticals Limited IPO
What is the IPO size of Akums Drugs and Pharmaceuticals Limited?
Akums Drugs and Pharmaceuticals Limited plans to raise ₹1,856.74 crores through its IPO.
What is the lot size for Akums Drugs and Pharmaceuticals IPO?
The lot size is 22 shares, with minimum investment amounts specified for different investor categories.
When will Akums Drugs and Pharmaceuticals IPO be listed?
The IPO listing date is scheduled for August 6, 2024, on both BSE and NSE.
